斯里兰卡COVID-19导致的残疾调整寿命年数:一项回顾性横截面研究
Ananda Rajitha Wickremasinghe1, Akila Dinethra Kumari Ariyasena1, Thushani Umesha Munasinghe1
1Depatment of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
BMJ public health
|February 28, 2025
概括
斯里兰卡的COVID-19健康负担,以残疾调整寿命年 (DALYs) 衡量,相对较低. 这项研究估计了跨年龄和性别的DALY,包括家庭成员的焦虑.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- COVID-19 已成为全球卫生面临的重大挑战.
- 估计健康负担对于有效的公共卫生干预至关重要.
- 根据残疾调整的寿命年 (DALYs) 是量化疾病影响的关键指标.
研究的目的:
- 用DALYs估计斯里兰卡COVID-19的健康负担.
- 分析不同年龄组和性别的COVID-19负担的变化.
- 包括与COVID-19患者家属经历的焦虑相关的DALY.
主要方法:
- 使用了回顾性研究设计.
- 数据来源于斯里兰卡卫生部的每日情况报告和每月流行病学报告.
- 对于2020年1月至2022年6月的COVID-19病例和相关焦虑,计算了DALY.
主要成果:
- 报告共有664,123例COVID-19病例,其中54%为男性.
- 病例死亡率为2.48%,女性的死亡率更高.
- 总DALY估计为269,606人,或每1000人中12.2人,女性的生命损失年数较高.
结论:
- 根据DALY评估,斯里兰卡的COVID-19健康负担相对其他国家相比相对较低.
- 岛屿地理和严格的政府措施可能有助于降低负担.
- 单独的DALY可能无法完全捕捉到大流行病的深刻经济和社会后果.
更多相关视频
相关概念视频
Factors Affecting Illness
4.1K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.1K
Immunodeficiency Diseases
890
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
890
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Pulmonary Tuberculosis I
215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis II
208
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
208
Pulmonary Tuberculosis V
163
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
163


